|
2024-08-09 |
2024-08-08 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
260,873
-4.0%
0.19
USD 50,009
|
260,873
-4.0%
|
0.19
|
USD 50,009
|
|
|
2024-08-09 |
2024-08-07 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
61,488
-0.9%
0.18
USD 11,197
|
61,488
-0.9%
|
0.18
|
USD 11,197
|
|
|
2024-08-07 |
2024-08-06 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
55,732
-0.8%
0.18
USD 10,188
|
55,732
-0.8%
|
0.18
|
USD 10,188
|
|
|
2024-08-07 |
2024-08-05 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
164,523
-2.4%
0.19
USD 30,996
|
164,523
-2.4%
|
0.19
|
USD 30,996
|
|
|
2024-08-05 |
2024-08-02 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
286,200
-4.0%
0.20
USD 57,354
|
286,200
-4.0%
|
0.20
|
USD 57,354
|
|
|
2024-08-05 |
2024-08-01 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
63,564
-0.9%
0.22
USD 13,743
|
63,564
-0.9%
|
0.22
|
USD 13,743
|
|
|
2024-07-30 |
2024-07-30 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
756,835
-9.5%
0.22
USD 167,185
|
756,835
-9.5%
|
0.22
|
USD 167,185
|
|
|
2024-07-30 |
2024-07-29 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
363,949
-4.4%
0.24
USD 85,637
|
363,949
-4.4%
|
0.24
|
USD 85,637
|
|
|
2024-07-30 |
2024-07-26 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
258,335
-3.0%
0.24
USD 62,440
|
258,335
-3.0%
|
0.24
|
USD 62,440
|
|
|
2024-06-24 |
2024-06-21 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
115,000
+20.3%
0.27
USD 30,717
|
115,000
+20.3%
|
0.27
|
USD 30,717
|
|
|
2024-06-24 |
2024-06-20 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
190,000
+50.6%
0.25
USD 48,108
|
190,000
+50.6%
|
0.25
|
USD 48,108
|
|
|
2024-06-20 |
2024-06-18 |
B
Purchase
|
Hahn Brian M.
SVP Finance, CFO
Officer
|
17,500
+32.9%
0.25
USD 4,335
|
17,500
+32.9%
|
0.25
|
USD 4,335
|
|
|
2023-09-25 |
2023-09-22 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
30,403
+8.8%
1.38
USD 41,956
|
30,403
+8.8%
|
1.38
|
USD 41,956
|
|
|
2023-09-25 |
2023-09-21 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
35,000
+11.3%
1.38
USD 48,300
|
35,000
+11.3%
|
1.38
|
USD 48,300
|
|
|
2023-05-18 |
2023-05-17 |
S
Sale
|
Hahn Brian M.
SVP Finance, CFO
Officer
|
3,700
-6.5%
1.95
USD 7,215
|
3,700
-6.5%
|
1.95
|
USD 7,215
|
|
|
2023-05-11 |
2023-05-10 |
B
Purchase
|
JUNIUS DANIEL M
Non-Executive Director
|
30,000
+47.4%
1.56
USD 46,800
|
30,000
+47.4%
|
1.56
|
USD 46,800
|
|
|
2023-05-09 |
2023-05-08 |
B
Purchase
|
Johnson Bruce S
SVP & Chief Commercial Officer
Officer
|
13,500
+10.8%
1.57
USD 21,195
|
13,500
+10.8%
|
1.57
|
USD 21,195
|
|
|
2023-02-28 |
2023-02-24 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
100,000
+1.2%
1.70
USD 170,000
|
100,000
+1.2%
|
1.70
|
USD 170,000
|
|
|
2023-02-23 |
2023-02-23 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
200,000
+2.4%
1.75
USD 350,760
|
200,000
+2.4%
|
1.75
|
USD 350,760
|
|
|
2023-02-23 |
2023-02-22 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
150,000
+1.8%
1.79
USD 268,995
|
150,000
+1.8%
|
1.79
|
USD 268,995
|
|
